In pharmacologic point of views, this agent has demonstrated a potent anti-MerTK effect, particularly in a human leukemia cell line (IC50 of 1.1 nM), and a somewhat lower effect in human solid cancer cell lines (around 300 nM) [24]. This evidence concerns the gene MERTK and leukemia.